Home › Compare › OXBOF vs RYLD

OXBOF vs RYLD: Dividend Comparison 2026

OXBOF yields 100000.00% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OXBOF wins by $4.832206901976048e+26M in total portfolio value
10 years
OXBOF
OXBOF
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full OXBOF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — OXBOF vs RYLD

📍 OXBOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOXBOFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OXBOF + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
OXBOF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OXBOF
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, OXBOF beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OXBOF + RYLD for your $10,000?

OXBOF: 50%RYLD: 50%
100% RYLD50/50100% OXBOF
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OXBOF buys
0
RYLD buys
0
No recent congressional trades found for OXBOF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOXBOFRYLD
Forward yield100000.00% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.832206901976048e+26M$44.5K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$4.8315851896727036e+26M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: OXBOF vs RYLD ($10,000, DRIP)

YearOXBOF PortfolioOXBOF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$10,010,700$10,000,000.00$11,914$1,213.65+$10.00M → OXBOF
2$9,366,505,842$9,355,794,392.52$14,099$1,351.30+$9366.49M → OXBOF
3$8,191,091,111,834$8,181,068,950,583.78$16,580$1,494.55+$8191091.10M → OXBOF
4$6,695,134,751,499,451$6,686,370,284,009,789.00$19,384$1,642.61+$6695134751.48M → OXBOF
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$22,535$1,794.70+$5114850040116.01M → OXBOF
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$26,063$1,950.00+$3652290278277141.00M → OXBOF
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$29,995$2,107.69+$2437583176648375296.00M → OXBOF
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$34,361$2,266.99+$1.5206125080790106e+21M → OXBOF
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$39,194$2,427.12+$8.866373796011065e+23M → OXBOF
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$44,525$2,587.35+$4.832206901976048e+26M → OXBOF

OXBOF vs RYLD: Complete Analysis 2026

OXBOF — Stock

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Full OXBOF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this OXBOF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OXBOF vs SCHDOXBOF vs JEPIOXBOF vs OOXBOF vs KOOXBOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.